SMTL ID : 8uwz.1

The structure of Raamsizumab in complex with VEGF121

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.50 Å

Oligo State

hetero-2-2-2-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain C: Y.39, N.75, S.95, L.97 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.2: 4 residues within 4Å: Chain D: E.73, S.74, N.75, L.97 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fellouse, F.A. et al., Raamsizumab: A Potent Synthetic Human Anti-VEGF Neutralizing Fab for Treatment of Ocular Neovascularization Diseases. to be published

Release Date

2024-11-13

Peptides

Raamsizumab heavy chain: AE
Raamsizumab light chain S1C variant: BF
Isoform VEGF121 of Vascular endothelial growth factor A, long form: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

E
A

B
D

F
B

C
E

D
F

Raamsizumab heavy chain

Raamsizumab light chain S1C variant

Isoform VEGF121 of Vascular endothelial growth factor A, long form

Related Entries With Identical Sequence